Home Authors Posts by Sarah Pringle

Sarah Pringle

Excellere Partners, David Kessenich, Robert A. Martin, private equity
Robert Martin co-founded Excellere in 2006 Denver firm spun out from KRG Third fund closed in 2015 Excellere Partners Co-Managing Partner David Kessenich is now the firm’s principal owner following the recent death of the Denver PE shop’s other co-founder, Robert A. Martin, a recent SEC filing shows. Martin, who co-founded the KRG Capital Partners spinout […]
JLL Partners, Daniel Agroskin, private equity, merger, M&A
JLL closed its seventh fund at $1 bln in April 2016 New York sponsor looks to invest early in underlooked themes Recent exits in pharma services: Patheon, BioClinica Daniel Agroskin is a managing director at JLL Partners, where he leads the New York private equity firm’s healthcare efforts and is a member of the management committee. […]
Forest Laboratories, Howard Solomon, David Solomon, Hildred Capital, healthcare, private equity, family office, merger, M&A, pharmaceuticals, Crown Laboratories
Family office has made 11 private investments in ~3 years Hildred likely to bring in outside capital in 6-12 months Solomon: Crown’s sales could reach several-hundred-million-dollar range in 1-2 years The family office launched by former Forest Laboratories executives may be on a path toward more sizable deals as it weighs bringing in third-party capital, according […]
SEC, Jina Choi, private equity
SEC to maintain independence under Trump administration Agency acknowledges need to protect retail investors SEC to monitor capital call facilities, co-investments, fees and expenses Co-investment and capital call facility disclosures will remain top of mind when it comes to private equity enforcement by the SEC, the regional director for the agency’s San Francisco office said […]
Rodeo Dental, healthcare, medical, private equity, merger, m&a
L Catterton-backed dental-implant provider ClearChoice Holdings LLC is on the auction block, according to three sources familiar with the matter. The company expects 2017 EBITDA of $50 million-plus. Goldman is offering sell-side advice.
KKR, Kohlberg Kravis Roberts, healthcare, private equity
PE giant opportunistic when it comes to sectors Relationship-building a key deal-sourcing element August buys: Envision unit, Covenant, PharMerica Jim Momtazee leads the healthcare investment team at KKR, one of the most active buyers in the sector in recent weeks. How has KKR’s healthcare investing strategy evolved over the past five years? The biggest change […]
Avista Capital Partners, Envigo International, veterinary, private equity, merger, M&A
Avista-sponsored SPAC buys Envigo Avista Capital owns Envigo peer MPI Research Preclinical contract services market has consolidated to 4 players of scale Avista Capital Partners’ ties to the nonclinical contract-research-services market extend well beyond Envigo International Holdings Inc, which this week was purchased by the healthcare SPAC founded by the firm’s execs. Besides an affiliation […]
Thomas H. Lee, Lee Equity Partners, Chris Witkowsky, private equity
Fund I closed in 2008 at ~$1.1 bln An interim bridge fund raised at least $315 mln in 2016 New York firm promoted five team members in February Lee Equity Partners plans to raise its next fund in 2018, the firm’s founder, Thomas H. Lee, said at Emerging Manager Connect East. Lee also indicated he would move out […]
Madison Capital, Adam Willis, private equity, merger, M&A
Healthcare makes up >20% of lender’s portfolio Unrealistic value expectations of “me too” companies lead to failed processes Diverse pool of capital providers drives up debt multiples Adam Willis serves as a managing director at Madison Capital Funding, where he heads up the lender’s healthcare efforts and leads a dedicated team. Madison, with more than […]
private equity, merger, M&A, TPG,
Q2 sees 127 announced PE deals vs. 75 in Q1; dollar volume also spikes Tech produces highest number of closed transactions TPG among most active in tech, supported by 3 funds with 3 different mandates A high-price environment hasn’t stopped traditional private equity firms from finding new investments, with sponsor-led dealmaking in tech fueling a […]

Copyright PEI Media

Not for publication, email or dissemination